ADMA Biologics Inc - stock earnings
ADMA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -17.6 million USD | 73.9 million USD |
| 2023Q3 | 2.6 million USD | 67.3 million USD |
| 2023Q2 | -6.4 million USD | 60.1 million USD |
| 2023Q1 | -12.8 million USD | 56.9 million USD |
| 2022Q4 | -25.9 million USD | 50.0 million USD |
| 2022Q3 | -20.5 million USD | 41.1 million USD |
| 2022Q2 | -18.4 million USD | 33.9 million USD |
| 2022Q1 | -35.2 million USD | 29.1 million USD |
| 2021Q4 | -16.6 million USD | 26.4 million USD |
| 2021Q3 | -17.7 million USD | 20.7 million USD |
| 2021Q2 | -18.9 million USD | 17.8 million USD |
| 2021Q1 | -18.4 million USD | 16.0 million USD |
| 2020Q4 | -19.4 million USD | 14.0 million USD |
| 2020Q3 | -16.9 million USD | 10.3 million USD |
| 2020Q2 | -20.2 million USD | 7.8 million USD |
| 2020Q1 | -19.2 million USD | 10.2 million USD |
| 2019Q4 | -10.6 million USD | 12.0 million USD |
| 2019Q3 | -11.4 million USD | 7.2 million USD |
| 2019Q2 | -13.2 million USD | 6.6 million USD |
| 2019Q1 | -13.1 million USD | 3.5 million USD |
| 2018Q4 | -18.0 million USD | 4.1 million USD |
| 2018Q3 | -15.1 million USD | 4.2 million USD |
| 2018Q2 | -14.7 million USD | 4.7 million USD |
| 2018Q1 | -17.8 million USD | 4.0 million USD |
| 2017Q4 | -13.0 million USD | 12.0 million USD |
| 2017Q3 | -15.2 million USD | 4.7 million USD |
| 2017Q2 | -9.0 million USD | 3.4 million USD |
| 2017Q1 | -6.5 million USD | 2.6 million USD |
| 2016Q4 | -4.6 million USD | 3.3 million USD |
| 2016Q3 | -4.3 million USD | 2.9 million USD |
| 2016Q2 | -6.0 million USD | 2.3 million USD |
| 2016Q1 | -4.6 million USD | 2.1 million USD |
| 2015Q4 | -4.6 million USD | 2.5 million USD |
| 2015Q3 | -5.1 million USD | 1.9 million USD |
| 2015Q2 | -4.7 million USD | 1.3 million USD |
| 2015Q1 | -3.6 million USD | 1.5 million USD |
| 2014Q4 | -3.6 million USD | 1.5 million USD |
| 2014Q3 | -3.4 million USD | 1.4 million USD |
| 2014Q2 | -4.0 million USD | 1.5 million USD |
| 2014Q1 | -5.9 million USD | 1.6 million USD |
| 2013Q4 | -4.7 million USD | 424031 USD |
| 2013Q3 | -2.7 million USD | 1.1 million USD |
| 2013Q2 | -4.9 million USD | 743270 USD |
| 2013Q1 | -3.2 million USD | 792935 USD |
| 2012Q4 | -2.3 million USD | 523284 USD |
| 2012Q3 | -3.2 million USD | 360338 USD |
| 2012Q2 | -1.2 million USD | 230096 USD |
| 2012Q1 | -597314 USD | 4400 USD |
| 2011Q4 | -8328 USD | ? USD |
| 2011Q3 | -5174 USD | ? USD |
| 2011Q2 | -11680 USD | ? USD |
| 2011Q1 | -4908 USD | ? USD |
| 2010Q4 | -5228 USD | ? USD |
| 2010Q3 | -4643 USD | ? USD |
| 2010Q2 | -7572 USD | ? USD |
| 2010Q1 | -4810 USD | ? USD |
| 2009Q4 | -4326 USD | ? USD |
| 2009Q3 | -3.8 million USD | ? USD |
| 2009Q2 | -20.0 million USD | ? USD |
| 2009Q1 | -10.9 million USD | ? USD |
| 2008Q4 | -7.1 million USD | ? USD |
| 2008Q3 | -24.9 million USD | ? USD |
| 2008Q2 | -24.9 million USD | ? USD |
| 2008Q1 | -16.1 million USD | ? USD |
| 2007Q4 | -11.2 million USD | ? USD |
| 2007Q3 | -5.3 million USD | ? USD |
| 2007Q2 | -29.7 million USD | ? USD |
| 2007Q1 | -21.2 million USD | ? USD |
| 2006Q4 | -19.1 million USD | ? USD |
| 2006Q3 | -14130 USD | ? USD |
ADMA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -28.2 million USD | 258.2 million USD |
| 2022 | -85.2 million USD | 154.1 million USD |
| 2021 | -84.5 million USD | 80.9 million USD |
| 2020 | -87.6 million USD | 42.2 million USD |
| 2019 | -57.0 million USD | 29.3 million USD |
| 2018 | -65.7 million USD | 17.0 million USD |
| 2017 | -43.8 million USD | 22.8 million USD |
| 2016 | -19.5 million USD | 10.7 million USD |
| 2015 | -18.0 million USD | 7.2 million USD |
| 2014 | -16.8 million USD | 5.9 million USD |
| 2013 | -15.5 million USD | 3.1 million USD |
| 2012 | -7.3 million USD | 1.1 million USD |
| 2011 | -26460 USD | ? USD |
| 2010 | -20526 USD | ? USD |
| 2009 | -20.0 million USD | ? USD |
| 2008 | -24.9 million USD | ? USD |
| 2007 | -29.7 million USD | ? USD |
| 2006 | -29.7 million USD | ? USD |
ADMA
Price: $6.91
52 week price:
Earnings Per Share: -0.13 USD
P/E Ratio: -48.11
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 2.7 million
Ebitda: -13.6 millionMarket Capitalization: 1.4 billion